217 related articles for article (PubMed ID: 21463127)
61. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
62. PI3K/Akt Cooperates with Oncogenic Notch by Inducing Nitric Oxide-Dependent Inflammation.
Villegas SN; Gombos R; García-López L; Gutiérrez-Pérez I; García-Castillo J; Vallejo DM; Da Ros VG; Ballesta-Illán E; Mihály J; Dominguez M
Cell Rep; 2018 Mar; 22(10):2541-2549. PubMed ID: 29514083
[TBL] [Abstract][Full Text] [Related]
63. Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T-cell acute lymphoblastic leukemia.
Yuan T; Wang J; Shi C; Wang Y; Xia B; Xu W; Yang H; Yang Y; Ye MT; Khalid S; Liang Y; Tian C; You MJ; Wang Y
Hematol Oncol; 2022 Apr; 40(2):249-257. PubMed ID: 34796518
[TBL] [Abstract][Full Text] [Related]
64. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.
Nan H; Han L; Ma J; Yang C; Su R; He J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1684-1692. PubMed ID: 29408595
[TBL] [Abstract][Full Text] [Related]
65. Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.
Shieh A; Ward AF; Donlan KL; Harding-Theobald ER; Xu J; Mullighan CG; Zhang C; Chen SC; Su X; Downing JR; Bollag GE; Shannon KM
Blood; 2013 Jun; 121(24):4884-93. PubMed ID: 23637129
[TBL] [Abstract][Full Text] [Related]
66. 20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.
Zhang H; Xu HL; Wang YC; Lu ZY; Yu XF; Sui DY
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614812
[TBL] [Abstract][Full Text] [Related]
67. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
Guo D; Ye J; Dai J; Li L; Chen F; Ma D; Ji C
Leuk Res; 2009 May; 33(5):678-85. PubMed ID: 19091404
[TBL] [Abstract][Full Text] [Related]
68. PTEN-opathies: from biological insights to evidence-based precision medicine.
Yehia L; Ngeow J; Eng C
J Clin Invest; 2019 Feb; 129(2):452-464. PubMed ID: 30614812
[TBL] [Abstract][Full Text] [Related]
69. Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of
Kuzilková D; Bugarin C; Rejlova K; Schulz AR; Mei HE; Paganin M; Biffi A; Biondi A; Kalina T; Gaipa G
Haematologica; 2022 Jun; 107(6):1293-1310. PubMed ID: 34670357
[TBL] [Abstract][Full Text] [Related]
70. PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.
Ibrahim MY; Nunez MI; Harun N; Lee JJ; El-Naggar AK; Ferrarotto R; Wistuba I; Myers J; Glisson BS; William WN
Head Neck; 2019 Mar; 41(3):615-622. PubMed ID: 30556200
[TBL] [Abstract][Full Text] [Related]
71. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
[TBL] [Abstract][Full Text] [Related]
72. Follicle loss and PTEN/PI3K/mTOR signaling pathway activated in LepR-mutated mice.
Xia H; Zhang R; Guan H; Zhang W
Gynecol Endocrinol; 2019 Jan; 35(1):44-48. PubMed ID: 30145913
[TBL] [Abstract][Full Text] [Related]
73. Sirtuin 1 Activation Suppresses the Growth of T-lymphoblastic Leukemia Cells by Inhibiting NOTCH and NF-κB Pathways.
Okasha SM; Itoh M; Tohda S
Anticancer Res; 2020 Jun; 40(6):3155-3161. PubMed ID: 32487610
[TBL] [Abstract][Full Text] [Related]
74. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.
Cullion K; Draheim KM; Hermance N; Tammam J; Sharma VM; Ware C; Nikov G; Krishnamoorthy V; Majumder PK; Kelliher MA
Blood; 2009 Jun; 113(24):6172-81. PubMed ID: 19246562
[TBL] [Abstract][Full Text] [Related]
75. Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition.
Habets RA; de Bock CE; Serneels L; Lodewijckx I; Verbeke D; Nittner D; Narlawar R; Demeyer S; Dooley J; Liston A; Taghon T; Cools J; de Strooper B
Sci Transl Med; 2019 May; 11(494):. PubMed ID: 31142678
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.
Chang YS; Gills JJ; Kawabata S; Onozawa M; Della Gatta G; Ferrando AA; Aplan PD; Dennis PA
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37800623
[TBL] [Abstract][Full Text] [Related]
77. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
Bentley VL; Veinotte CJ; Corkery DP; Pinder JB; LeBlanc MA; Bedard K; Weng AP; Berman JN; Dellaire G
Haematologica; 2015 Jan; 100(1):70-6. PubMed ID: 25281505
[TBL] [Abstract][Full Text] [Related]
78. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.
Medyouf H; Gusscott S; Wang H; Tseng JC; Wai C; Nemirovsky O; Trumpp A; Pflumio F; Carboni J; Gottardis M; Pollak M; Kung AL; Aster JC; Holzenberger M; Weng AP
J Exp Med; 2011 Aug; 208(9):1809-22. PubMed ID: 21807868
[TBL] [Abstract][Full Text] [Related]
79. Clonal evolution enhances leukemia-propagating cell frequency in T cell acute lymphoblastic leukemia through Akt/mTORC1 pathway activation.
Blackburn JS; Liu S; Wilder JL; Dobrinski KP; Lobbardi R; Moore FE; Martinez SA; Chen EY; Lee C; Langenau DM
Cancer Cell; 2014 Mar; 25(3):366-78. PubMed ID: 24613413
[TBL] [Abstract][Full Text] [Related]
80. Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line.
Podshivalova K; Wang EA; Hart T; Salomon DR
Leuk Res; 2018 Nov; 74():1-9. PubMed ID: 30269036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
